UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Additive manufacturing of natural biopolymers and composites for bone tissue engineering

Materials horizons, 2020-01, Vol.7 (8), p.211-227

2020

Volltextzugriff (PDF)

Effects of amylose content on the mechanical properties of starch-hydroxyapatite 3D printed bone scaffolds

Additive manufacturing, 2019-12, Vol.30, p.100817, Article 100817

2019

Volltextzugriff (PDF)

613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A368-A369

2020

Volltextzugriff (PDF)

3D printed hydroxyapatite-nacre-starch based bone grafts: Evaluation of biological and mechanical properties

Journal of materials research, 2022-06, Vol.37 (12), p.2033-2044

2022

Volltextzugriff (PDF)

Starch-hydroxyapatite composite bone scaffold fabrication utilizing a slurry extrusion-based solid freeform fabricator

Additive manufacturing, 2018-12, Vol.24, p.47-59

2018

Volltextzugriff (PDF)

Cytotoxic and osteogenic effects of crocin and bicarbonate from calcium phosphates for potential chemopreventative and anti-inflammatory applications in vitro and in vivo

Journal of materials chemistry. B, Materials for biology and medicine, 2020-03, Vol.8 (10), p.2048-2062

2020

Volltextzugriff (PDF)

Abstract 3376: HER2-XPAT and EGFR-XPAT: Pro-drug T-cell engagers (TCEs) engineered to address o n -target, o ff -tumor toxicity with potent efficacy in vitro and in vivo and large safety margins in NHP

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3376-3376

2020

Volltextzugriff (PDF)

Abstract 1824: HER2-XPAT, a novel protease-activatable T-cell engager (TCE) with potent T-cell activation and efficacy in solid tumors and large safety margins in non-human primate (NHP)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1824-1824

2021

Volltextzugriff (PDF)

Abstract PS17-11: Her2-xpat, a novel protease-activatable prodrug t-cell engager (tce), exhibits potent t-cell activation and efficacy in her2 tumors, yielding large predicted safety margins based on non-human primate (nhp)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS17-11-PS17-11

2021

Volltextzugriff (PDF)

Abstract P193: AMX-818, a novel prodrug HER2-XPAT T-cell engager (TCE) with potent T cell activation, proteolytic cleavage and efficacy in xenograft tumors, and wide safety margins in NHP (Non Human Primate)

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P193-P193

2021

Volltextzugriff (PDF)

Correction: Additive manufacturing of natural biopolymers and composites for bone tissue engineering

Materials horizons, 2020-08, Vol.7 (8), p.2169-217

2020

Volltextzugriff (PDF)

Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors

Nature cancer, 2023-04, Vol.4 (4), p.485-501

2023

Volltextzugriff (PDF)

Effects of chitosan-loaded hydroxyapatite on osteoblasts and osteosarcoma for chemopreventative applications

Materials Science & Engineering C, 2020-10, Vol.115, p.111041-111041, Article 111041

2020

Volltextzugriff (PDF)

Biological and Mechanical Performance of 3D Printed Composite Scaffolds and Assessment of Chemopreventative and Anti-inflammatory Agents for Bone Tissue Engineering Applications

Koski, Caitlin McKenzie

2019

Volltextzugriff (PDF)

Additive Manufacturing of Polymers

Additive Manufacturing, 2020, p.25-42

2nd Edition, 2020

Volltextzugriff (PDF)

Variation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Clinical Trial

Academic emergency medicine, 2001-06, Vol.8 (6), p.636-641

2001

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(14)

Publikationsform

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Materials Science
(7)
Technology
(6)
Hydroxyapatite
(5)
Biomedical Materials
(4)
Humans
(4)
Materials Science, Multidisciplinary
(4)
Komposit
(3)
Solid Freeform Fabrication
(3)
Starch
(3)
Three Dimensional Printing
(3)
Tissue Engineering
(3)
3d-Druck
(2)
Additive Fertigung
(2)
Animals
(2)
Apoptosis
(2)
Biocompatibility
(2)
Biopolymers
(2)
Bone Cancer
(2)
Bone Scaffolds
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Additive manufacturing of natural biopolymers and composites for bone tissue engineering

Effects of amylose content on the mechanical properties of starch-hydroxyapatite 3D printed bone scaffolds

613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP)

3D printed hydroxyapatite-nacre-starch based bone grafts: Evaluation of biological and mechanical properties

Starch-hydroxyapatite composite bone scaffold fabrication utilizing a slurry extrusion-based solid freeform fabricator

Cytotoxic and osteogenic effects of crocin and bicarbonate from calcium phosphates for potential chemopreventative and anti-inflammatory applications in vitro and in vivo

Abstract 3376: HER2-XPAT and EGFR-XPAT: Pro-drug T-cell engagers (TCEs) engineered to address o n -target, o ff -tumor toxicity with potent efficacy in vitro and in vivo and large safety margins in NHP

Abstract 1824: HER2-XPAT, a novel protease-activatable T-cell engager (TCE) with potent T-cell activation and efficacy in solid tumors and large safety margins in non-human primate (NHP)

Abstract PS17-11: Her2-xpat, a novel protease-activatable prodrug t-cell engager (tce), exhibits potent t-cell activation and efficacy in her2 tumors, yielding large predicted safety margins based on non-human primate (nhp)

Abstract P193: AMX-818, a novel prodrug HER2-XPAT T-cell engager (TCE) with potent T cell activation, proteolytic cleavage and efficacy in xenograft tumors, and wide safety margins in NHP (Non Human Primate)

Correction: Additive manufacturing of natural biopolymers and composites for bone tissue engineering

Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors

Effects of chitosan-loaded hydroxyapatite on osteoblasts and osteosarcoma for chemopreventative applications

Biological and Mechanical Performance of 3D Printed Composite Scaffolds and Assessment of Chemopreventative and Anti-inflammatory Agents for Bone Tissue Engineering Applications

Additive Manufacturing of Polymers

Variation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Clinical Trial

Suchergebnisse filtern